One Platform. Complete Clinical Development Intelligence.
How Beacon Helps Clinical Development Teams:
- Benchmark trial designs, endpoints and eligibility criteria against relevant studies to strengthen protocol strategy and programme differentiation.
- Track competitor trials, protocol changes and emerging clinical readouts to understand how the development landscape is evolving.
- Compare patient populations, dosing strategies, biomarkers and outcomes to identify proven approaches and avoid repeatable pitfalls.
- Support faster progression decisions with connected drug, trial and scientific intelligence spanning preclinical evidence through clinical outcomes.
Why Leading Clinical Development Teams Choose Beacon
Beacon goes beyond trial registries, generic databases and AI tools, delivering the clinical depth and scientific context needed to benchmark studies, interpret readouts and reduce development risk.
Modality & Disease-Specific Datasets
Analyze the full competitive landscape. Includes the 20-30% of data AI engines miss.
Subject Matter Expert-Led Curation
Curated by scientists, trusted by strategists to deliver decision-grade intelligence
Holistic Preclinical & Clinical Data
From discovery to clinic, depth and context no generic platform can match.
Granular Ontologies & Modality-Specific Data
From “who is active” to “what wins” benchmark what drives differentiation.
Structured, AI-ready Data
Power your analytics and automation workflows. Gold-standard data in, gold-standard decisions out.
Why Generic Databases and AI Engines Fall Short
The difference is clear. Beacon delivers decision-grade intelligence designed specifically for drug development.
| What Matters | Generic Databases | AI Engines | Beacon |
| Landscape Completeness | Broad, but shallow | Highly variable; significant omissions | Access the full landscape, including the 20-30% others miss |
| Preclinical depth | Limited or absent | Largely missing from model outputs | Core strength, curated from grey literature upwards |
| Scientific granularity | Company, indication, phase of development | Unstructured narrative text | 90+ modality-specific filters and ontologies |
| Curation | Largely automated aggregation | None, model inference only | Curated by sector scientists, zero tolerance for errors |
| Consistency | Varies with refresh cycles and versioning | Answers vary between identical queries | Deterministic, the same query returns the same result |
| Defensibility | Partial sourcing; re-validation needed | Sources often missing, paraphrased or fabricated | 100% traceable, board and portfolio ready |
Strengthen Clinical Development with Decision-Grade Intelligence
Benchmark trial strategy, interpret emerging evidence and make clinical development decisions with confidence.
Search